Art

J-GLOBAL ID：201902207028780268   Reference number：19S0408338

Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes

Author (40)： Asakura, Keiichi (Japanese Safety Pharmacology Society (JSPS)) ,  Asakura, Keiichi (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Asakura, Keiichi (Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)) ,  Asakura, Keiichi (Consortium for Safety Assessment using Human iPS Cells (CSAHi)) ,  Asakura, Keiichi (Nippon Shinyaku Co. Ltd.) ,  Hayashi, Seiji (Japanese Safety Pharmacology Society (JSPS)) ,  Hayashi, Seiji (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Hayashi, Seiji (Nippon Shinyaku Co. Ltd.) ,  Osada, Tomoharu (Japanese Safety Pharmacology Society (JSPS)) ,  Osada, Tomoharu (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Osada, Tomoharu (LSI Medience Corporation) ,  Kasai, Chieko (Japanese Safety Pharmacology Society (JSPS)) ,  Kasai, Chieko (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Kasai, Chieko (Astellas Pharma Inc.) ,  Ando, Hiroyuki (Japanese Safety Pharmacology Society (JSPS)) ,  Ando, Hiroyuki (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Ando, Hiroyuki (Consortium for Safety Assessment using Human iPS Cells (CSAHi)) ,  Ando, Hiroyuki (Ono Pharmaceutical Co. Ltd.) ,  Kanda, Yasunari (Japanese Safety Pharmacology Society (JSPS)) ,  Kanda, Yasunari (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Kanda, Yasunari (National Institute of Health Sciences (NIHS)) ,  Sekino, Yuko (Japanese Safety Pharmacology Society (JSPS)) ,  Sekino, Yuko (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Sekino, Yuko (National Institute of Health Sciences (NIHS)) ,  Sawada, Kohei (Japanese Safety Pharmacology Society (JSPS)) ,  Sawada, Kohei (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Sawada, Kohei (Eisai Co. Ltd.) ,  Ojima, Atsuko (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Ojima, Atsuko (Eisai Co. Ltd.) ,  Taniguchi, Tomohiko (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Taniguchi, Tomohiko (Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)) ,  Taniguchi, Tomohiko (Consortium for Safety Assessment using Human iPS Cells (CSAHi)) ,  Taniguchi, Tomohiko (Eisai Co. Ltd.) ,  Miyamoto, Norimasa (Japan iPS Cardiac Safety Assessment (JiCSA)) ,  Miyamoto, Norimasa (Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)) ,  Miyamoto, Norimasa (Consortium for Safety Assessment using Human iPS Cells (CSAHi)) ,  Miyamoto, Norimasa (Eisai Co. Ltd.) ,  Nakamori, Chiaki (Consortium for Safety Assessment using Human iPS Cells (CSAHi)) ,  Nakamori, Chiaki (Taisho Pharmaceutical Co.Ltd.) ,  Nagasawa, Chiho (Consortium for Safety Assessment using Human iPS Cells (CSAHi))
Material： Journal of Pharmacological and Toxicological Methods
Volume： 75  Page： 17-26  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 1056-8719  CODEN： JPTME 
Country of issue： United States (USA)  Language： English (EN)

Terms in the title (1)： IPS